QuantuMDx Group Ltd: QuantuMDx announces approval of its Rap

QuantuMDx announces approval of its Rapid Q-POCTM SARS-CoV-2 assay in the UK under CTDA legislation NEWCASTLE UPON TYNE, UK, 22 February 2022. QuantuMDx Group Limited ("QuantuMDx"), today announces

Related Keywords

United Kingdom , Jeff Glushakow , Chris Gardner , Matthew Neal , Lindsey Neville , Jonathan Ohalloran , David Wilson , Kostenloser Wertpapierhandel , Nigel Barnes , Marketing Communications , Consilium Strategic Communications , Quantumdx Group Limited , Technical Validation Group , Group Limited , United Kingdom Health Security Agency , Medical Devices , Coronavirus Test Device Approvals , Product Profile , Chief Executive , Vitro Diagnostics , Vitro Diagnostics Directive , Marketing Communications Manager , Quantumdx , Group , Nnounces , Approval , Rapid , Octm , Cars , Essay , Under , Bitda , Legislation ,